ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Bevacizumab Prolongs Survival In Patients With Advanced Colorectal Cancer

November 26, 2004

NCAB Member Seeks Broder’s Resignation, Gets No support

June 3, 1994

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990

March 8, 1985

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991